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CLINICAL PRACTICE
Clinical Vignette
Examining Patient Conceptions: A Case of Metastatic Breast
Cancer in an African American Male to Female Transgender
Patient
Amar Dhand, MD, DPhil1 and Gurpreet Dhaliwal, MD2,3
1Department of Neurology, University of California San Francisco, San Francisco, CA, USA; 2Department of Medicine, San Francisco Veterans
Affairs Medical Center and University of California San Francisco, San Francisco, CA, USA; 3Medical Service (111), San Francisco Veterans
Affairs Medical Center, San Francisco, CA, USA.
An African American male to female transgender pa-
tient treated with estrogen detected a breast lump that
was confirmed by her primary care provider. The
patient refused mammography and 14 months later
she was diagnosed with metastatic breast cancer with
spinal cord compression. We used ethnographic inter-
views and observations to elicit the patient’s concep-
tions of her illness and actions. The patient identified
herself as biologically male and socially female; she
thought that the former protected her against breast
cancer; she had fears that excision would make a breast
tumor spread; and she believed injectable estrogens
were less likely than oral estrogens to cause cancer.
Analysis suggests dissociation between the patient’s
social and biological identities, fear and fatalism around
cancer screening, and legitimization of injectable hor-
mones. This case emphasizes the importance of eliciting
and interpreting a patient’s conceptions of health and
illness when discordant understandings develop be-
tween patient and physician.
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INTRODUCTION
Patients and physicians frequently inhabit different social
worlds. The discussion between these individuals about illness
and treatment is therefore prone to misunderstandings. Often
these misunderstandings are recognized by the participants
and settled through questions and answers. On occasion,
however, an impasse develops where the physician struggles to
understand the patient’s behaviors. A patient’s rejection of
evaluations and treatments that offer potential for well-
established biomedical improvement can be particularly per-
plexing. When common explanations (e.g. access to care,
socioeconomic factors, etc.) are not apparent, the clinician
may resort to inaccurate assumptions or abandon the pursuit
of an explanation, which can lead to detrimental outcomes1.
This case report presents an African American transgender
patient who declined evaluation of a breast mass and subse-
quently developed metastatic breast cancer. It outlines an
ethnographic approach to engage cultural and psychosocial
elements on an occasion where a seemingly inexplicable
impasse arose between provider and patient.
METHODS
Data for this report was generated by three in-depth interviews
with the patient, daily observations in the hospital for nearly
four weeks, two phone interviews with the primary care
provider, and review of the medical record. Interviews with
the patient were conducted while the patient was psychiatri-
cally stable and receiving daily quetiapine. Questions for the
interviews were based on Kleinman’s2,3 ethnographic ap-
proach with greater detail elicited by using Hammersley and
Atkinson’s4 principles of qualitative interviewing. A single
reviewer (AD) analyzed the data using constant comparison
procedures5 including repeated reading of the data, compari-
son between different passages, literature consultation, and
clustering of data with derivation of themes using TamsAnaly-
zer6. We obtained informed consent from the patient before the
research began.
CASE
A 58-year-old African American male to female transgender
patient was brought to the emergency room for inability to
walk and urinate.
Approximately 14 months prior to presentation the patient’s
primary care provider noticed a lump at the 4 o’clock position
of her left breast. The patient declined mammography and
biopsy, which were not discussed again on subsequent visits.
Eleven days prior to admission, the patient developed low back
pain and lower extremity weakness. She gradually became
unable to walk to the bathroom and resorted to urinating in
cups and clothing near her bed. Three days prior to admission,
she was unable to urinate and her lower abdomen became
swollen.
The patient’s medical history included schizoaffective disor-
der and hypertension. She received estrogen treatment from
local clinics between 1969–1978 and 1995–1997 and under-
went silicone breast implantation in Mexico. Her medications
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included benazepril, hydrochlorothiazide, metoprolol, and
unspecified psychiatric medications that she had not taken
for the last six days. Her mother had survived an unknown
cancer that was treated with chemotherapy. The patient lived
in community housing and worked at local car washes and
soup kitchens. She did not smoke tobacco or drink alcohol in
excess, but she did use intravenous cocaine, speed, and
methamphetamines regularly.
A massively distended bladder, decreased rectal tone,
decreased muscle strength in the lower extremities (left >
right), and bilateral ankle clonus were detected on examina-
tion. Vital signs and the remainder of the general physical
exam were normal except for a 5×5 cm firm, non-tender mass
in the 3 to 4 o’clock position of the left breast and fixed
adenopathy in the left axilla. MRI of the spine showed cord
compression at T3 by a soft tissue mass and marrow signal
changes in the cervical, thoracic, and lumbar vertebral bodies
(Fig. 1). The patient repeatedly refused fine needle aspiration of
the breast mass, but after the urging of multiple physicians,
she agreed. Pathology revealed tumor cells that had 3–4+
positivity for estrogen receptor and 4+ positivity for progester-
one receptor consistent with adenocarcinoma.
Her neurologic function improved after ten rounds of
radiation therapy and high dose steroids. After further treat-
ment with tamoxifen and prednisone, MRI revealed regression
of the T3 mass and decompression of the spinal cord but
persistent diffuse bony metastasis with a compression fracture
at T12. Her outpatient oncologist continued tamoxifen and
planned to add zoledronic acid as her prednisone was tapered
and discontinued.
Two months after admission, the patient had normal
bladder function and walked with an assistive device at a
rehabilitation hospital. Her breast mass was unchanged at her
last outpatient appointment.
PATIENT’S CONCEPTIONS
The patient stated that she first noticed the breast mass ten
months prior to her admission (underestimating the true
interval by four months). She understood that her primary
care provider advised mammography and biopsy, but she
declined because “I had many lumps because of the silicone.”
When asked what she thought about the breast cancer, she
stated: “It probably involves silicone mixed with tissue.” She did
not expect the lump to be breast cancer because: “I have a
male chest with hormones and silicone, and I didn’t expect to
get breast cancer. Men and women cancers are different.”
When asked what caused the problem, she stated: “Drinking
the water in Bayview [a San Francisco neighborhood].” She
followed up with the association: “My landlord has breast
cancer as well.” She explained why she did not want a biopsy:
“I didn’t want to cut it because that will make it spread. I also
didn’t want to know [the results]. My landlord has breast cancer
and had both breasts reduced. I also didn’t want to hurt my
heart muscle, which is on the left. If the lump were on the right,
then that would be okay.”
The patient also made a distinction between estrogen pills
and injections: “Pills are worse than injections. They give you
breast cancer. Injections are more pure. They make you into a
woman. Injections don’t cause breast cancer because you pee it
out in 24 hours. Pills stay longer because you take the pill
everyday. Pills can cause breast cancer.”
DISCUSSION
Although both participants identified a breast lump and
discussed the possibility of cancer in this case, the patient
declined investigations until metastases developed. The rea-
sons for declining a seemingly simple diagnostic test with the
potential for curative treatment were not apparent. However,
in-depth investigation of the patient’s conceptions provided
explanations and demonstrated how physicians may uncover
beliefs that are not expected because of their different educa-
tional, social, or demographic status. Here we explore three
cultural and psychosocial issues derived from the patient’s
conceptions that provide insight into the patient’s actions and
the development of misunderstandings.
This patient displayed a complex identity construction. Her
social identity was feminine highlighted by her preference for a
female name and female body signifiers, including her silicone
breasts, hip padding, and choice of clothing. At the same time,
she self-identified her chest as a “male chest” that she believed
provided immunity against breast cancer. Therefore her female
social identity and her male biological identity were dissociated
when the patient was evaluating her risk for breast cancer.
Although the Diagnostic and Statistical Manual of Mental
Disorders-IV-Text Revision7 has diagnostic criteria for gender
identity disorder, defined as “evidence of strong identification
of the opposite gender and persistent discomfort with one’s
assigned sex,” it does not describe this complex identity
construction. In such cases, the clinician will gain more
insight from the patient rather than the reference book. This
approach provides the opportunity to learn how transgender
patients may attribute explanatory power to these identity
constructions, thereby affecting their risk assessments,
healthcare decisions, and behaviors.
Figure 1. MRI without contrast showing T3 cord compression by a
soft tissue mass (large arrow) and marrow signal changes in the
cervical, thoracic, and lumbar vertebral bodies (small arrows).
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The patient’s fear of ‘cutting’ the mass and denial of the
results are well described in the literature on socioeconomi-
cally disadvantaged populations. Loehrer et al.8 report 37% of
their sample of county hospital patients with cancer believed
that “surgery causes cancer to spread.” Peek et al.9 describe
that despite health education efforts in their sample of low-
income African American women, many of their participants
held the idea that “surgery causes cancer to spread (and would
therefore be unnecessary or harmful),” and that a common
response to this fear was denial and repression. The authors
discuss that these fears, denial, and repression surrounding
screening lead to cultural norms of delaying and avoiding testing
until diseases manifested, a trend now well-established in the
literature10–12. Therefore, a clinician should consider that a
patient’s aversion to testing is not exclusively an individual trait;
rather it may be a manifestation of a larger cultural pattern
characterizing the patient’s social context.
Patients’ beliefs about medications influence their behaviors
and interactions with the medical system. In this case, the
patient preferred injections because they were effective in her
transformation and she felt that rapid expulsion rendered
them less harmful than daily pills. Differences between the
experiences of taking injections versus oral medication may
underlie this patient’s perception. Pills, although prescribed by
a medical professional, are self-administered by the patient on
a daily basis. Injectable estrogens, conversely, are usually
administered by a medical professional in a clinic setting once
a month (although other frequencies exist). Therefore, injec-
tions have decreased presence in daily life, and may be
associated with greater legitimacy and safety by being admin-
istered in a medical setting by a professional, who performs the
key role of gatekeeper in the transformation process13. It is
important for providers to appreciate how patients’ conception
of the effects and risks of medication may be influenced by
route, frequency, and source of administration.
This case illustrates discordance between clinician and
patient understandings and its unfortunate consequence. This
patient’s actions were partly informed by her specific ideas
about biological identity, fears of medical testing, and medica-
tion risks and benefits. Although eliciting this culturally tuned
history is a challenge for the busy physician, it is imperative in
such cases. In addition to the ethnographic approach revealed
in this paper, we provide a set of practical strategies derived
from cultural and communications literature to aid in these
interactions (text box 1)3,14–16. The goal of this process is not to
assure compliance with the physician’s biomedical treatment
regimen, but to reach a point of common understanding to meet
the biopsychosocial needs of the patient. Utilizing such strategies
provides identification of the impasse, clarification of the mis-
understandings, and opportunities for shared decision-making.
Text Box 1: Strategies for physicians to engage cultural and psychosocial 
elements 
• Begin by asking the patient what they understand about their illness and 
treatment options (“What do you call this illness?” “What do you believe 
caused this problem?” “What treatments do you think are possible?” “What 
do you fear about this illness or treatment?”) 
• Seek to understand the context (e.g. environmental and social) which 
dominate the patient’s concerns 
• Share clinician’s understanding of the patient’s world 
• Frame explanations using the patient’s ideas and vocabulary 
• Schedule multiple visits for extended discussion 
• Engage other people of influence in the patient’s life (family, spiritual leader, 
friends) 
• Engage nurses, social workers, and other health care professionals who have 
experience with specific patient populations 
may 
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